Lebrun D - Search Results

1

Efficacy and tolerability of the ifosfamide-epirubicin combination in relapsed ovarian cancer.

Joly F, Bourgeois H, Floquet A, Chinet-Charrot P, Meyer F, Lebrun D, Hamond K, Leroy C, Heron JF. Joly F, et al. Among authors: lebrun d. Int J Gynecol Cancer. 2006 Jan-Feb;16(1):77-82. doi: 10.1111/j.1525-1438.2006.00288.x. Int J Gynecol Cancer. 2006. PMID: 16445614

2

Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experience.

Alexandre J, Ray-Coquard I, Selle F, Floquet A, Cottu P, Weber B, Falandry C, Lebrun D, Pujade-Lauraine E; GINECO. Alexandre J, et al. Among authors: lebrun d. Ann Oncol. 2010 Dec;21(12):2377-2381. doi: 10.1093/annonc/mdq257. Epub 2010 May 21. Ann Oncol. 2010. PMID: 20494964 Free article.

3

A multicenter phase II study with triptorelin (sustained-release LHRH agonist) in advanced or recurrent endometrial carcinoma: a French anticancer federation study.

Lhommé C, Vennin P, Callet N, Lesimple T, Achard JL, Chauvergne J, Luporsi E, Chinet-Charrot P, Coudert B, Couette JE, Guastalla JP, Lebrun D, Ispas S, Blumberg J. Lhommé C, et al. Among authors: lebrun d. Gynecol Oncol. 1999 Nov;75(2):187-93. doi: 10.1006/gyno.1999.5538. Gynecol Oncol. 1999. PMID: 10525370 Clinical Trial.

4

Navelbine in advanced ovarian epithelial cancer: a study of the French oncology centers.

George MJ, Heron JF, Kerbrat P, Chauvergne J, Goupil A, Lebrun D, Guastalla JP, Namer M, Bugat R, Ayme Y, et al. George MJ, et al. Among authors: lebrun d. Semin Oncol. 1989 Apr;16(2 Suppl 4):30-2. Semin Oncol. 1989. PMID: 2652318 Clinical Trial. No abstract available.

5

Sequential trial of initial chemotherapy for advanced cancer of the head and neck. DDP versus DDP + 5-fluorouracil.

Coninx P, Nasca S, Lebrun D, Panis X, Lucas P, Garbe E, Legros M. Coninx P, et al. Among authors: lebrun d. Cancer. 1988 Nov 1;62(9):1888-92. doi: 10.1002/1097-0142(19881101)62:9<1888::aid-cncr2820620903>3.0.co;2-m. Cancer. 1988. PMID: 3048643 Clinical Trial.

6

Staging of head-and-neck cancer.

Marechal F, Coninx P, Legros M, Nasca S, Lebrun D, Cattan A. Marechal F, et al. Among authors: lebrun d. Lancet. 1986 Feb 1;1(8475):275. doi: 10.1016/s0140-6736(86)90810-x. Lancet. 1986. PMID: 2868288 No abstract available.

7

Immunoscintigraphy with indium-111 labeled monoclonal antibodies: the importance of a good display method.

Liehn JC, Hannequin P, Nasca S, Lebrun D, Fernandez-Valoni A, Valeyre J. Liehn JC, et al. Among authors: lebrun d. Clin Nucl Med. 1989 Mar;14(3):187-91. doi: 10.1097/00003072-198903000-00010. Clin Nucl Med. 1989. PMID: 2736845

8

A new approach to image subtraction in immunoscintigraphy: preliminary results.

Liehn JC, Hannequin P, Nasca S, Lebrun D, Cattan A, Valeyre J. Liehn JC, et al. Among authors: lebrun d. Eur J Nucl Med. 1987;13(8):391-6. doi: 10.1007/BF00292489. Eur J Nucl Med. 1987. PMID: 3325290

9

Early death during initial chemotherapy of squamous cell carcinoma of the oro- or hypopharynx.

Moutel K, Nasca S, Panis X, Lebrun D, Merol JC, Coninx P. Moutel K, et al. Among authors: lebrun d. Anticancer Res. 1997 Jan-Feb;17(1B):647-51. Anticancer Res. 1997. PMID: 9066595

10

Prognostic significance of routine clinical and laboratory data in advanced head and neck cancers.

Himberlin C, Merol JC, Nasca S, Panis X, Lebrun D, Desoize B, Legros M, Coninx P. Himberlin C, et al. Among authors: lebrun d. Anticancer Res. 1996 Mar-Apr;16(2):1005-10. Anticancer Res. 1996. PMID: 8687091

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

239 results

Search Page